Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen
- PMID: 7875189
- DOI: 10.1007/BF00191169
Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen
Abstract
The indirect effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen was studied in 16 healthy male volunteers. In an open, cross-over design, 200 mg ketoprofen was administered as a gastric-juice-resistant, sustained-release tablet once daily during two periods of 5 days. A low-calorie/low-fat diet (LCFD) was given in the first period and a high-calorie/high-fat diet (HCFD) in the second period. The first meal on each day was given 4 h after drug intake. Ketoprofen plasma concentrations were measured over 24 h after the first dose on day 1 and over 36 h after the final dose on day 5 of each period. On average, plasma concentrations of ketoprofen were higher with the LCFD than with the HCFD. With the HCFD there was a tendency to longer absorption-lag times on day 5. The maximum concentration and the area under the curve over one 24-h dosage period (AUC0-24) were significantly higher with the LCFD, both on day 1 and on day 5. For AUC0-24 the differences were on average 15% (day 1) and 24% (day 5). The same tendency was observed for the amount excreted in urine over 24 h (Ae), but the difference was only significant on day 1 (14%). The elimination rate constant (K beta) and the mean residence time were similar for the two diets, both on day 1 and on day 5. From these results, we conclude that there was an acute indirect effect of diet when a meal was had 4 h after intake of the medication.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Influence of diet on the single-dose pharmacokinetics of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate.Biol Pharm Bull. 1997 Oct;20(10):1111-5. doi: 10.1248/bpb.20.1111. Biol Pharm Bull. 1997. PMID: 9353575 Clinical Trial.
-
Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):787-793. doi: 10.1007/s13318-015-0313-2. Eur J Drug Metab Pharmacokinet. 2016. PMID: 26590950 Clinical Trial.
-
Bioavailability of a new ketoprofen formulation for once-daily oral administration.Int J Pharm. 2002 Jul 8;241(1):165-72. doi: 10.1016/s0378-5173(02)00230-2. Int J Pharm. 2002. PMID: 12086732 Clinical Trial.
-
Clinical pharmacokinetics of dexketoprofen.Clin Pharmacokinet. 2001;40(4):245-62. doi: 10.2165/00003088-200140040-00002. Clin Pharmacokinet. 2001. PMID: 11368291 Review.
-
Clinical pharmacokinetics of ketoprofen and its enantiomers.Clin Pharmacokinet. 1990 Sep;19(3):197-217. doi: 10.2165/00003088-199019030-00004. Clin Pharmacokinet. 1990. PMID: 2203580 Review.
Cited by
-
Development and Validation a UPLC-MS/MS Method for Quantification of Pentoxifylline in Beagle Plasma: Application for Pharmacokinetic Study of Food Effect.Drug Des Devel Ther. 2023 Nov 28;17:3551-3561. doi: 10.2147/DDDT.S434492. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 38046282 Free PMC article.
-
Serum concentrations of antidepressants, antipsychotics, and antiepileptics over the bariatric surgery procedure.Eur J Clin Pharmacol. 2021 Dec;77(12):1875-1885. doi: 10.1007/s00228-021-03182-1. Epub 2021 Jul 16. Eur J Clin Pharmacol. 2021. PMID: 34269840 Free PMC article.
-
Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate.Eur J Clin Pharmacol. 2008 Oct;64(10):1027-30. doi: 10.1007/s00228-008-0524-4. Epub 2008 Jul 8. Eur J Clin Pharmacol. 2008. PMID: 18607579 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources